Literature DB >> 4390958

Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.

A G Wilson, O G Brooke, H J Lloyd, B F Robinson.   

Abstract

The effect on exercise tolerance of racemic propranolol has been assessed in eight angina pectoris patients and compared with that of dexpropranolol (the dextro isomer of propranolol), practolol (I.C.I. 50172), and saline. Dexpropranolol has the same local anaesthetic action as propranolol with negligible beta-adrenergic receptor blocking activity, while practolol is a cardio-selective beta-adrenergic blocking agent which does not have local anaesthetic activity.Saline and dexpropranolol had no significant effect on exercise time; racemic propranolol and practolol improved exercise tolerance in six subjects, the response to the two drugs being very similar in individual patients. It was concluded that the beneficial effect of propranolol in angina pectoris results from its action as a beta-adrenergic receptor blocking agent and is not due to its local anaesthetic, or quinidine-like, activity.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4390958      PMCID: PMC1629770          DOI: 10.1136/bmj.4.5680.399

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

2.  Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic acitivity in patients with angina pectoris.

Authors:  D J Battock; H Alvarez; C A Chidsey
Journal:  Circulation       Date:  1969-02       Impact factor: 29.690

3.  The treatment of angina pectoris with a new beta-receptor blocking agent (H 56/28).

Authors:  P Björntorp
Journal:  Acta Med Scand       Date:  1967-09

4.  Propranolol in patients with angina pectoris.

Authors:  R E Gianelly; R H Goldman; B Treister; D C Harrison
Journal:  Ann Intern Med       Date:  1967-12       Impact factor: 25.391

5.  The prophylactic value of propranolol in angina pectoris.

Authors:  R Rabkin; D P Stables; N W Levin; M M Suzman
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

6.  Multicenter trial of propranolol in angina pectoris.

Authors:  R H Grant; P Keelan; R J Kernohan; J C Leonard; L Nancekievill; K Sinclair
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

7.  Treatment of angina pectoris with beta-receptor blockade, mode of action.

Authors:  P Björntorp
Journal:  Acta Med Scand       Date:  1968-10

8.  Effects of propranolol on exercise tolerance in angina pectoris.

Authors:  J Hamer; E Sowton
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

9.  Clinical evaluation of verapamil in angina pectoris.

Authors:  G Sandler; G A Clayton; S G Thornicroft
Journal:  Br Med J       Date:  1968-07-27

10.  Trasicor in angina pectoris: a double-blind trial.

Authors:  D F Wilson; O F Watson; J S Peel; A S Turner
Journal:  Br Med J       Date:  1969-04-19
View more
  18 in total

Review 1.  The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.

Authors:  J D Fitzgerald
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

2.  Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.

Authors:  H H Harms; L Gooren; A J Spoelstra; C Hesse; L Verschoor
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

3.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

4.  Comparison of effects of propranolol and practolol on exercise tolerance in angina pectoris.

Authors:  D J Coltart
Journal:  Br Heart J       Date:  1971-01

Review 5.  Experimental approaches to the prophylaxis and treatment of ischaemic heart disease.

Authors:  J D Fitzgerald
Journal:  Postgrad Med J       Date:  1971-01       Impact factor: 2.401

6.  A comparison of the effects of propranolol and practolol on the exercise tolerance in angina pectoris.

Authors:  D J Coltart; J Hamer
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739

7.  General concepts in the use of beta-blockers: the relative roles of specific and unspecific effects.

Authors:  H Brunner; P R Hedwall; M Meier
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

8.  Cardioselective beta-adrenergic blockade.

Authors:  J D Fitzgerald
Journal:  Proc R Soc Med       Date:  1972-09

9.  Acute haemodynamic effects of practolol in patients with idiopathic hypertrophic subaortic stenosis.

Authors:  H J Matlof; D C Harrison
Journal:  Br Heart J       Date:  1973-02

Review 10.  Beta-adrenergic receptor blocking drugs in angina pectoris.

Authors:  B N Prichard
Journal:  Drugs       Date:  1974       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.